Jason Ku Wang

Investing in biotech | prev @harvardmed @stanford @meta @path_ai

[Sean Ku Wang @SeanKuWang]

Thrilled to share that I'll be joining @Stanford as an Assistant Professor of Ophthalmology and retina specialist!

My lab will open September 2026 and aims to accelerate the development of safe and effective genetic therapies.

[Sean Ku Wang @SeanKuWang]

Excited to share a preprint from @HowardYChang's lab, co-led w/ @Jiaying_Gia! We combine single-cell multiomics, enhancer mapping, & functional testing of human RPE and choroid to nominate causal variants in macular degeneration. @suragnair @anshulkundaje

https://t.co/jzdXbUMKRC

[Joyce Kang @joycebkang]

Excited that our single-cell eQTL study of HLA genes is out now in @NatureGenet! ⭐️ https://t.co/bYtyjliKF8
Huge thx to @soumya_boston @saorisakaue @yluo86 for their guidance

Check out this great News & Views by the Gaffney lab describing the key points: https://t.co/J0i6AvdSzJ

[Sean Ku Wang @SeanKuWang]

Thrilled to share a new paper from the @HowardYChang lab in @NatureBiotech, co-led with Robert Chen! We systematically engineer circular RNAs for stronger translation, boosting yields >200-fold and enabling potent and durable protein production in vivo 1/

https://t.co/AygRISmSuG

[Travis Hughes @travishughes]

Unlike 99% of MD and MD-PhD students who apply to residency from Harvard, I did not match. 1/n

[Sean Ku Wang @SeanKuWang]

Excited to share my first preprint with @HowardYChang! We apply #singlecell RNA/ATAC-seq, HiChIP, eQTLs, and #deeplearning to the human retina to nominate causal SNPs in five eye diseases. w/ @suragnair @KraftKaterina @joycebkang @anshulkundaje & others

https://t.co/R1eS6dkKva

[Sean Ku Wang @SeanKuWang]

Our review on targeting microglia in degenerative eye diseases is now out in @FrontImmunol ! Great to write this with Connie Cepko and highlight many potential therapies in this space!

https://t.co/bKZdSvxdQV

[James Diao @JamesADiao]

1/ Can a simple thumb trick save thousands from sudden cardiac death?

Now out in #AmJCardiology, @arjunmanrai, @GloriaJWu, and I investigate the questionable clinical utility of a newly proposed “digital”😉 biomarker.

https://t.co/lRqDoo8W2s

[Arjun (Raj) Manrai @arjunmanrai]

Excited to announce that I’ve joined the core faculty of @HarvardDBMI and that my lab has moved to @HarvardDBMI @HarvardMed. I’m thrilled to return to where I trained with @zakkohane & to join colleagues transforming medicine w/ computation. We’re hiring!

https://t.co/MThV2ePpzM

[Qaultcin @charliecwlee]

Excited to share our new study in @Nature with the Kasper Lab @BrighamResearch 🦠🐁

We focus on how distinct branching patterns of glycosphingolipids produced by the human commensal, B. fragilis, can have immunomodulatory activity on colonic NKT cells.

https://t.co/BWbfUpMCEb

[Joyce Kang @joycebkang]

Thrilled to share Symphony, our method for single-cell reference mapping, out now in @NatureComms 🎉: https://t.co/Ob6uqWmTe3 @ilyakorsunsky @soumya_boston

[Sean Ku Wang @SeanKuWang]

CD47 is best known as a cancer target, but can the "don't eat me signal" also help protect cells?

Our latest paper in @JCI_insight suggests yes! Using CD47, we design an AAV gene therapy that slows retinal degeneration in mice. w/ @YunluSawyerXue

https://t.co/rRPh32ESDW

[Kiran Musunuru @kiranmusunuru]

A milestone in modern medicine: 1st therapeutic in vivo gene editing in human patients!

From Julian Gillmore, @intelliatweets & colleagues out today @NEJM:

https://t.co/4xyyFHAwAj

Here’s an overview of a new potential treatment for transthyretin (ATTR) amyloidosis.

(thread)

[Jason Ku Wang @jkuwang]

@arjunmanrai @JamesADiao @PDSoros Congrats @JamesADiao! 🎉

[PD Soros Fellowships @PDSoros]

We're thrilled to announce the 2021 Paul & Daisy Soros Fellows: 30 New Americans—immigrants and children of immigrants—pursuing graduate school, who exemplify the extraordinary contributions of immigrants to the United States. 🗽🇺🇸🎓

https://t.co/7rlLY3W8XD

[Jason Ku Wang @jkuwang]

Press release: https://t.co/IWqRQz4gVf

[Jason Ku Wang @jkuwang]

Excited to share our work @Path_AI out in @NatureComms
on building interpretable pipelines for predicting molecular phenotypes from cancer histology images! 🔬🧬

https://t.co/tMv8RdSRHk

[Jason Ku Wang @jkuwang]

Tweetorial: https://t.co/vgoywVieE7

[PathAI @Path_AI]

Excited to announce our research study on an interpretable pipeline for predicting molecular phenotypes from cancer pathology images! @amarotaylorw @jamesadiao @jkuwang @wanfungchu

https://t.co/BoOZxLtZgL
Tweetorial to follow ⬇️

[James Diao @JamesADiao]

Now out in @NatureComms: AI-derived image features for interpretable molecular prediction! 🔬🧬

Proud to have led this work at @Path_AI alongside my amazing classmates @jkuwang and @wanfungchui.

Tweetorial + press release linked below:

https://t.co/7HCGgscOyu